ClinicalThoughts

Share

Program Content

Activities

  • PEP-in-Pocket
    PEP-in-Pocket for HIV Prevention in Canada
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 07, 2023

    Expires: March 05, 2024

  • LA ART at CROI 2023
    Long-Acting Antiretroviral Therapy at CROI 2023: Here to Stay and, Perhaps, Just Beginning
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 07, 2023

    Expires: March 05, 2024

  • Mpox in Advanced HIV
    Mpox in Advanced HIV: A New AIDS-Defining Condition in the Americas and Beyond?
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 14, 2023

    Expires: March 12, 2024

  • HIV/STI Prevention: Cis Women
    HIV and STI Prevention in Cisgender Women: Studies from CROI 2023 Influencing My Practice in Eastern Europe
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 10, 2023

    Expires: March 08, 2024

  • HIV and the Liver
    HIV and the Liver at CROI 2023
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 14, 2023

    Expires: March 12, 2024

  • ART Adherence: Urine Testing
    Improving ART Adherence With Point-of-Care Urine Testing: Viewpoints From Africa
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 20, 2023

    Expires: March 18, 2024

  • CROI 2023: HIV PrEP
    PrEP Data From CROI 2023: Protecting Patients From HIV
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 20, 2023

    Expires: March 18, 2024

  • Updates on Islatravir: Western European Perspectives
    Islatravir Updates From CROI 2023: Perspectives From Western Europe
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 17, 2023

    Expires: March 15, 2024

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc.

ViiV Healthcare